Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

Cranial Nerve VI Palsy Emergency

Buscar en contenido

Contenido:

jueves, 14 de febrero de 2013

Hipertensión pulmonar (Parte 2)


PULMONARY HYPERTENSION UPDATE
Part 2: Treatment (Review JAMA)
PulmCCM Feb 12, 2013. By Brett Ley MD.
"There are 3 classes of pulmonary vasodilator drugs: phosphodiesterase-5 inhibitors (PDE-5 inhibitors, e.g. sildenafil, tadalafil), endothelin receptor antagonists (ERAs, e.g. bosentan, ambrisentan), and prostacyclins (epoprostenol, iloprost, treprostinil). Because the large trials have focused on PAH, currently only WHO group 1 has a clear indication for these medications. Their use in other WHO groups is an active area of research, but as of now their potential benefits and harms in these groups are largely unclear. Calcium channel blockers are a fourth class with specific indications."